Frances M. Jagla Law Professional

206-428-3104 (direct)
312-616-5700 (fax)
Seattle Office

Email Attorney
Download V-Card

Related Practices

Education

Valparaiso University School of Law, J.D., 1984

Indiana University, B.A. in Political Science, 1981

Frances M. Jagla

Counsel

Ms. Jagla is involved in all aspects of trademark, copyright, and unfair competition counseling and litigation. She has substantial U.S. and international experience in name development, clearance filing, registration, maintenance and enforcement of trademarks and copyrights for Fortune 100 companies. She possesses in-depth knowledge of trademark related acquisitions, divestitures, licensing, and Internet domain name matters.

Ms. Jagla has spent the majority of her career as in-house counsel in the pharmaceutical, healthcare and software industries. She led the trademark practice at Abbott Laboratories where she was responsible for the trademark strategies behind many blockbuster healthcare products including HUMIRA, KALETRA, NORVIR and BIAXIN and was instrumental in the trademark development for the spin-off of the medical device business into HOSPIRA. She has also served as the Senior Lead Attorney for trademarks at Microsoft Corporation during its development and launch of Windows Vista and Microsoft Office 2007. She was the founding member of the Law Office of Frances M. Jagla, PLLC, where she spent her time working with pharmaceutical companies who were encountering difficulties with FDA and EMEA approval of their new brands, USAN and INN designations.

Ms. Jagla is a frequent lecturer on a variety of trademark issues including international clearance and filing strategies and healthcare related topics.

Professional Affiliations

  • MedERRS, Institute for Safe Medication Practices (Board of Trustees, 2005-Present)
  • International Trademark Association (INTA) (Board of Directors, 2005-2007; Subcommittee Chair: Madrid Protocol, 2004; Board of Directors, Executive Committee, Secretary, 1995-1997; Annual Meeting Chair, 1997)
  • Pharmaceutical Trade Mark Group (Board of Directors, 2004)
  • Illinois State Bar Association
  • Washington State Bar Association
  • Intellectual Property Owners Association (IPO)
  • Indiana University Alumni Association

Articles and Publications

  • "The Intersection of the FDA and Trademark Law", Co-authored with Boris Umansky, Leydig, Voit and Mayer
  • "Impact of Madrid Protocol on U.S. Practitioners: An In-House Perspective," Co-authored with Danny Marti, Kilpatrick Stockton

Honors

  • Recipient of the Paul A. Welter 1st Annual Award for Excellence in Trademark Law. Merchant & Gould/William Mitchell School of Law, 2007
  • Recipient of Microsoft Corporate Marketing Group's Most Valued Partner for two

Representative Matters

  • Acquisition of Knoll AG
  • Spin-off of Abbott Laboratories' Hospital Products Division into Hospira
  • Divestiture of Abbott Laboratories Animal Health and Agriculture Divisions
  • Negotiations with the United States Adopted Names Council and the World Health Organization for adoption of preferred non-proprietary names (USAN and INN)
  • Negotiations with FDA and EMEA for approval of preferred trademarks for pharmaceutical products.

Speaking Engagements and Presentations

  • Co-host with Anne Naffziger an INTA roundtable discussion, “Policing Trademarks on the Internet and Web 2.0,” Seattle, January 19, 2010
  • "Trademarks and the Internet - Three Things You Should Know" CAIL (Center for American and International Law) Annual IP Meeting, November 10-11, 2008
  • "FDA Bootcamp-Naming the Product: the Intersection of FDA and Trademark Law," AIPLA Annual Meeting, October 23-25, 2008
  • "The Future of Pharmaceutical Trademarks," PTMG (Pharmaceutical Trade Mark Group) Autumn Meeting, October 1-4, 2008
  • "Strategies for the International Protection of Intellectual Property," Inside Counsel Super Conference, 2007
  • "Adherence to Madrid Protocol and Protection for Famous Names," USPTO/ASEAN Trademark Office Officials Meeting/Bangkok, 2006
  • "International Trademark Enforcement and Filing Strategies," INTA Meeting China Trademark Owners/Beijing, 2005
  • "United States FDA and European EMEA - Pharmaceutical Trademarks," Pharmaceutical Trademark Group Annual Meeting, 2004
  • Co-chair of "INTA Madrid Protocol and its impact on US Practitioners", 2003 Washington, D.C, Oak Brook, Illinois, and San Francisco, California

Bar Admissions and Registrations

  • Illinois, 1989
  • Washington, 2007
  • Indiana, 1984

Courts

  • U.S. District Court for the Northern District of Illinois
  • U.S. District Court for the Northern District of Indiana
  • U.S. District Court for the Western District of Washington